Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibiotic prophylaxis for transrectal prostate biopsy-a new strategy.
Antsupova V, Nørgaard N, Bisbjerg R, Nygaard Jensen J, Boel J, Jarløv JO, Arpi M. Antsupova V, et al. Among authors: bisbjerg r. J Antimicrob Chemother. 2014 Dec;69(12):3372-8. doi: 10.1093/jac/dku293. Epub 2014 Aug 11. J Antimicrob Chemother. 2014. PMID: 25114164
Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study.
Boesen L, Nørgaard N, Løgager V, Balslev I, Bisbjerg R, Thestrup KC, Winther MD, Jakobsen H, Thomsen HS. Boesen L, et al. Among authors: bisbjerg r. JAMA Netw Open. 2018 Jun 1;1(2):e180219. doi: 10.1001/jamanetworkopen.2018.0219. JAMA Netw Open. 2018. PMID: 30646066 Free PMC article.
A predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for prostate biopsies.
Boesen L, Thomsen FB, Nørgaard N, Løgager V, Balslev I, Bisbjerg R, Thomsen HS, Jakobsen H. Boesen L, et al. Among authors: bisbjerg r. Prostate Cancer Prostatic Dis. 2019 Dec;22(4):609-616. doi: 10.1038/s41391-019-0149-y. Epub 2019 Apr 15. Prostate Cancer Prostatic Dis. 2019. PMID: 30988407 Clinical Trial.
Fatigue, quality of life and metabolic changes in men treated with first-line enzalutamide versus abiraterone plus prednisolone for metastatic castration-resistant prostate cancer (HEAT): a randomised trial protocol.
Kvorning Ternov K, Sønksen J, Fode M, Lindberg H, Kistorp CM, Bisbjerg R, Palapattu G, Østergren PB. Kvorning Ternov K, et al. Among authors: bisbjerg r. BMJ Open. 2019 Sep 11;9(9):e030218. doi: 10.1136/bmjopen-2019-030218. BMJ Open. 2019. PMID: 31511288 Free PMC article.
Fatigue, health-related quality-of-life and metabolic changes in men treated with enzalutamide or abiraterone acetate plus prednisone for metastatic castration-resistant prostate cancer: A randomised clinical trial (HEAT).
Ternov KK, Sønksen J, Fode M, Lindberg H, Kistorp C, Bisbjerg R, Faber J, Klausen TW, Palapattu G, Østergren PB. Ternov KK, et al. Among authors: bisbjerg r. Eur J Cancer. 2022 Aug;171:75-84. doi: 10.1016/j.ejca.2022.04.034. Epub 2022 Jun 13. Eur J Cancer. 2022. PMID: 35709600 Clinical Trial.
23 results